Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Hims vs MDLive

Hims and MDLive sell different medications; this is what separates them.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed (not clinically reviewed). Not medical advice · How we verify contentLast reviewed
Hims logo

Hims

6.8
★★★☆☆3.4/5

Best for: knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC

Visit Hims →
VS
MDLive logo

MDLive

5.2
★★★☆☆2.6/5

Best for: seeing what it charges before you answer any medical questions

Visit MDLive →

If you are choosing between Hims and MDLive, price alone will not settle it. Hims leads our six-part score, 6.8 to 5.2. One of the two has an FDA warning letter on record, covered below.

Hims vs MDLive price

Hims publishes $199 a month. MDLive does not post a GLP-1 price we can quote, so you would only learn its cost after an intake.

Medications and formats

Hims lists semaglutide and tirzepatide; MDLive does not name its drug.

On format, Hims prices compounded injections and brand-name pens, while MDLive posts no priced format.

If you want the FDA-approved brand rather than a compounded version, Hims is the only one of the two with a brand-name price.

Where each one treats patients

Hims lists 50 states, and MDLive does not publish where it ships.

Pricing

Hims

StartingCompounded
$199/mo
semaglutide
StartingBrand-name
$299/mo
tirzepatide

Brand Zepbound from $299/mo medication-only; requires Hims Weight Loss Membership ($149/mo)

MDLive

Pricing not publicly listed.

What each price covers

Hims' price also covers the medication itself, which MDLive does not claim.

Hims is silent on shipping and lab work.

MDLive is silent on the clinician visit, shipping, lab work and coaching.

That matters most for the drug: unless MDLive confirms otherwise, budget for medication on top of its listed price.

Hims

Covered by the monthly price

Medication

In the price

Clinician visits

Charged on top

Shipping

Not stated

Lab work

Not stated

Coaching

Charged on top

MDLive

Covered by the monthly price

Medication

Charged on top

Clinician visits

Not stated

Shipping

Not stated

Lab work

Not stated

Coaching

Not stated

Where each one scores higher

Overall, Hims scores 6.8 and MDLive 5.2 out of 10.

Hims is stronger on effectiveness (10.0 vs 5.0), trust & safety (7.0 vs 6.5) and accessibility (10.0 vs 5.0).

MDLive is stronger on support (5.0 vs 3.0).

Value and user experience are within half a point.

How we score

Hims

6.8/10

Overall

MDLive

5.2/10

Value25%

3.0A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
5.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

7.0A
vs
B
6.5

Accessibility10%

10.0A
vs
B
5.0

Support10%

3.0A
vs
B
5.0

FDA warning letters

The FDA sent Hims a warning letter dated September 9, 2025 (letter 716567), and it is still open.

MDLive has no FDA warning letter on record with us.

Features & Coverage

FeatureHimsMDLive
Starting Price$199/moNot published
Features2 features✓8 features
States Available50Not disclosed
Compounded✓ Yes—
Brand Name✓ Yes—
FSA/HSA Accepted——
FDA Warning Letters1 letter✓None

About Hims

Hims is a major men's telehealth brand. Its weight loss offering is compounded semaglutide on a 6-month plan.

Read our full Hims review →

About MDLive

There is no single published cash price at MDLive; what you pay tracks your coverage. The company sits inside Evernorth/Cigna and says it reaches over 50 million people via health insurance and employer benefits, while still permitting out-of-pocket direct visits. The anti-obesity GLP-1s Wegovy and Zepbound are available only on a routine Primary Care visit, at the clinician's discretion, never through urgent care. Four states are carved out: Florida, Louisiana, Mississippi and New Jersey. Dermatology, behavioral health, urgent care and primary care round out the service.

Read our full MDLive review →

Pros & Cons

Hims

What we like

  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication
  • Serves all 50 states
  • Names 4 pharmacies that fill its prescriptions, which most sellers do not

Watch-outs

  • Not included in the monthly price: clinician visits, coaching
  • The FDA has issued Hims a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
  • Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality

MDLive

What we like

  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • We found no FDA warning letters issued to MDLive

Watch-outs

  • Not included in the monthly price: medication
  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license

Our Verdict

Winner: Hims

Hims wins this one, 6.8 to 5.2, above all for knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC. MDLive fits better if seeing what it charges before you answer any medical questions is your priority.

Choose Hims if…

You want knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC and an opening price near $199 a month.

Choose MDLive if…

You want seeing what it charges before you answer any medical questions.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

9.0

bmiMD

Starting below a standard dose, with microdose tiers

6.7

RxSpan MD

Knowing which pharmacy fills the vial: it names Belmar Pharmacy

6.6

Luvo Health

Moving between compounded and brand without changing seller

Hims vs MDLive: FAQ

Only Hims publishes a price ($199 a month). MDLive quotes after sign-up.
No. Hims lists semaglutide and tirzepatide; MDLive lists no named drug.
Hims lists 50 states; MDLive does not publish where it ships. Confirm your state before paying.
Only Hims includes the medication itself.
Hims has an open FDA warning letter from September 9, 2025. MDLive has none.
No. Neither Hims nor MDLive pays us anything.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.